[Management of severe atopic dermatitis].
Chavigny
J M
JM
Clinique Dermatologique, CHU Hôtel-Dieu, Nantes.
Alzieu
P
P
Milpied
B
B
Dutartre
H
H
Debons
M
M
Stalder
J F
JF
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D003876:Dermatitis, Atopic / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D004781:Environmental Exposure / Q000009:adverse effects; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D018579:Patient Selection; D012307:Risk Factors; D012720:Severity of Illness Index; D013256:Steroids
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D006634:Histamine H1 Antagonists; D007166:Immunosuppressive Agents; D013256:Steroids